Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Clinical trial NCT00541281 · COMPLETED

Trial details

NCT number: NCT00541281
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Resistant Prostate Cancer Metastatic Prostate Cancer

Start date: 2003-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.